Tue, April 25, 2023

Tessa Romero Maintained (XENE) at Buy with Increased Target to $55 on, Apr 25th, 2023

Tessa Romero of JP Morgan, Maintained "Xenon Pharmaceuticals Inc." (XENE) at Buy with Increased Target from $54 to $55 on, Apr 25th, 2023.

Tessa has made no other calls on XENE in the last 4 months.



There are 2 other peers that have a rating on XENE. Out of the 2 peers that are also analyzing XENE, 0 agree with Tessa's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Tessa


  • Serge Belanger of "Needham" Reiterated at Strong Buy and Held Target at $50 on, Friday, April 21st, 2023
  • Brian Abrahams of "RBC Capital" Reiterated at Buy and Held Target at $51 on, Wednesday, March 22nd, 2023